Richter Oliver N, Dorn Christoph, Rösing Ben, Flaskamp Christian, Ulrich Uwe
Department of Obstetrics and Gynecology, University of Bonn School of Medicine, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.
Arch Gynecol Obstet. 2005 Feb;271(2):143-7. doi: 10.1007/s00404-003-0591-9. Epub 2004 Jan 27.
As a cytotoxic product of activated monocytes, macrophages, and lymphocytes, tumor necrosis factor alpha (TNF-alpha)--together with other cytokines and growth factors--is an important component in the immune response of the human organism. In addition, TNF-alpha plays a central role in neoangiogenesis. Because of its cytotoxicity with regard to several tumor cells and its motility-hindering effect on human sperm, TNF-alpha is considered to be a significant pelvic mediator of female sterility.
The goal of our study was to determine as to whether or not an increased TNF-alpha secretion by peritoneal macrophages (PM) can be measured in female patients with endometriosis compared with healthy subjects, and if TNF-alpha secretion can be correlated with the activity of endometriosis.
During infertility work-up, 100 female patients underwent a diagnostic laparoscopy. In accordance with the rAFS classification as well as from the macroscopic aspect of the degree of activity of the endometriosis, the patients were divided as follows: an endometriosis-free control group with a completely normal pelvic status (n=35) and three groups with increasing stages of endometriosis (n=65). In the control group (Group 1), the TNF-alpha concentrations (median values with minimum / maximum) were 6.2 pg/ml (1.9/10.2), in Group 2 with rAFS stage I/II less active endometriosis 56.33 pg/ml (39.5/71.2), in Group 3 with rAFS stage I/II but highly active endometriosis 81.41 pg/ml (68.4/98.7), while in Group 4 with rAFS stage III/IV 200,15 pg/ml (182.6/226.8), respectively.
In conclusion, we were able to show that the TNF-alpha secretion of PM was significantly higher in patients with proven endometriosis compared to the control group. These results were found to be statistically significant and were in accordance with the histological findings. Thus, due to its immunomodulating potential, TNF-alpha may be a marker of both activity and stage of endometriosis.
作为活化单核细胞、巨噬细胞和淋巴细胞产生的细胞毒性产物,肿瘤坏死因子α(TNF-α)与其他细胞因子和生长因子一起,是人体免疫反应的重要组成部分。此外,TNF-α在新血管生成中起核心作用。由于其对多种肿瘤细胞的细胞毒性以及对人类精子的运动阻碍作用,TNF-α被认为是女性不育的重要盆腔介质。
我们研究的目的是确定与健康受试者相比,子宫内膜异位症女性患者的腹膜巨噬细胞(PM)分泌的TNF-α是否增加,以及TNF-α分泌是否与子宫内膜异位症的活动相关。
在不孕症检查期间,100名女性患者接受了诊断性腹腔镜检查。根据rAFS分类以及子宫内膜异位症活动程度的宏观方面,将患者分为以下几组:盆腔状态完全正常的无子宫内膜异位症对照组(n = 35)和子宫内膜异位症分期增加的三组(n = 65)。对照组(第1组)中,TNF-α浓度(最小值/最大值的中位数)为6.2 pg/ml(1.9/10.2),第2组为rAFS I/II期轻度活动的子宫内膜异位症,浓度为56.33 pg/ml(39.5/71.2),第3组为rAFS I/II期但高度活动的子宫内膜异位症,浓度为81.41 pg/ml(68.4/98.7),而第4组为rAFS III/IV期,浓度为200.15 pg/ml(182.6/226.8)。
总之,我们能够表明,与对照组相比,经证实患有子宫内膜异位症的患者PM分泌的TNF-α明显更高。这些结果具有统计学意义,并且与组织学结果一致。因此,由于其免疫调节潜力,TNF-α可能是子宫内膜异位症活动和分期的标志物。